Bibliography
- Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation 2005;112:3562-08
- Ford ES. Trends in mortality from all causes and cardiovascular disease among hypertensives and nonhypertensives adults in the United States. Circulation 2011;123:1737-44
- Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: antihypertensive drug therapy in black patients. Ann intern Med 2004;141:614-27
- Prichard BNC, Gillam PMS. Treatment of hypertension with propranolol. Br Med J 1969;1:7-16
- Humphreys GS, Delvin DG. Ineffectiveness of propranolol in hypertensive Jamaicans. Br Med J 1968;2:601-3
- Grell GAC. Propanolol in black hypertensives. Br Med J 1978;2:358
- Seedat YK. Propanolol in the South African non-white hypertensive patient. S Afr Med J 1971;45:284-5
- Seedat YK. Trial of atenolol and chlorthalidone for hypertension in black South Africans. Br Med J 1980;281:1241-7
- Seedat YK. Hypertension in developing nations in sub-Saharan Africa. J Human Hypertension 2000;14:739-47
- Seedat YK, Rayner BL. South African hypertension guideline 2011. S Afr Med J 2012;102:57-84
- Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond better to calcium channel and diuretics than to ACE inhibitors and beta-adrenergic blockers? A systematic review. BMC Med 2013;11:141
- Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks. An update of the International Society of Hypertension in Blacks consensus statement. Hypertension 2010;56:780-800